The time course of the return of upper limb bradykinesia after cessation of subthalamic stimulation in Parkinson's disease

被引:11
|
作者
Keresztenyi, Zoltan
Valkovic, Peter
Eggert, Thomas
Steude, Ulrich
Hermsdoerfer, Joachim
Laczko, Jozsef
Boetzel, Kai [1 ]
机构
[1] Univ Munich, Dept Neurol, D-8000 Munich, Germany
[2] Semmelweis Univ, Dept Biomech, H-1085 Budapest, Hungary
[3] Comenius Univ, Dept Neurol 2, Bratislava, Slovakia
[4] Univ Munich, Dept Neurosurg, Munich, Germany
[5] Hosp Munchen Bogenhausen, Clin Neuropsychol Res Grp, Munich, Germany
关键词
Parkinson's disease; subthalamic stimulation; bradykinesia;
D O I
10.1016/j.parkreldis.2006.12.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To investigate the time span within which bradykinesia re-occurs, we registered movement parameters immediately after the termination of deep brain stimulation of the subthalamic nucleus (STN) in nine Parkinson patients with chronically implanted bilateral STN electrodes. Two repetitive movements were investigated: finger-tapping and forearm pronation-supination. When stimulation was switched off, the amplitude and velocity of the investigated movements significantly declined, but the frequency did not. The time course of this decline was modeled by an exponential function that yielded time constants between 15 and 30 s. The effect of stimulation had completely disappeared within 1 min. These results suggest that it is necessary to wait at least for 1 min after the end of stimulation before performing further assessments. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:438 / 442
页数:5
相关论文
共 50 条
  • [21] Efficacy of Subthalamic Neural Closed-loop Deep Brain Stimulation for Bradykinesia in Parkinson's Disease
    Bronte-Stewart, Helen
    Afzal, Muhammad Furqan
    Velisar, Anca
    Anidi, Chioma
    NEUROLOGY, 2018, 90
  • [22] Subthalamic stimulation for Parkinson's disease
    Benabid, AL
    Koudsié, A
    Benazzouz, A
    Fraix, V
    Ashraf, A
    Le Bas, JF
    Chabardes, S
    Pollak, P
    ARCHIVES OF MEDICAL RESEARCH, 2000, 31 (03) : 282 - 289
  • [23] Cortical activation improvement obtained by subthalamic nucleus stimulation in Parkinson's disease and its relation to bradykinesia
    Devos, D
    Derambure, P
    Bourriez, JL
    Cassim, F
    Blond, S
    Guieu, JD
    Destee, A
    Defebvre, L
    NEUROLOGY, 2002, 58 (07) : A56 - A56
  • [24] Analysis of lower limb bradykinesia in Parkinson's disease patients
    Kim, Ji-Won
    Kwon, Yuri
    Kim, Yu-Mi
    Chung, Hong-Young
    Eom, Gwang-Moon
    Jun, Jae-Hoon
    Lee, Jeong-Whan
    Koh, Seong-Beom
    Park, Byung Kyu
    Kwon, Dae-Kyu
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2012, 12 (02) : 257 - 264
  • [25] Personality Changes After Subthalamic Nucleus Stimulation in Parkinson's Disease
    Brezovar, Simon
    Pazek, Lucija
    Kavcic, Martin
    Georgiev, Dejan
    Trost, Maja
    Flisar, Dusan
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) : 1231 - 1240
  • [26] Weight gain mecanisms in Parkinson's disease after subthalamic stimulation
    Bannier, S.
    Morio, B.
    Montaurier, C.
    Boirie, Y.
    Durif, F.
    MOVEMENT DISORDERS, 2006, 21 : S477 - S477
  • [27] The Psychiatric and Neuropsychiatric Symptoms After Subthalamic Stimulation for Parkinson's Disease
    Mosley, Philip E.
    Marsh, Rodney
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2015, 27 (01) : 19 - 26
  • [28] Suicide Attempts after Subthalamic Nucleus Stimulation for Parkinson's Disease
    Rodrigues, Ana M.
    Rosas, Maria J.
    Gago, Miguel F.
    Sousa, Claudia
    Fonseca, Rosalia
    Linhares, Paulo
    Basto, Margarida A.
    Sousa, Graca
    Garrett, Carolina
    Vaz, Rui
    EUROPEAN NEUROLOGY, 2010, 63 (03) : 176 - 179
  • [29] Subthalamic nucleus stimulation in Parkinson’s disease
    Roberto Marconi
    Andrea Landi
    Franco Valzania
    Neurological Sciences, 2008, 29 : 389 - 391
  • [30] Stimulation of the subthalamic nucleus in Parkinson's disease
    Benabid, A. L.
    Chabardes, S.
    Seigneuret, E.
    Torres, N.
    Xia, R.
    Fraix, V.
    Krack, P.
    Polosan, M.
    Bougerol, T.
    Pollak, R.
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 535 - 536